These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18564730)

  • 1. Modulatory effects of Cissus quadrangularis on periodontal regeneration by bovine-derived hydroxyapatite in intrabony defects: exploratory clinical trial.
    Jain A; Dixit J; Prakash D
    J Int Acad Periodontol; 2008 Apr; 10(2):59-65. PubMed ID: 18564730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
    Batista EL; Novaes AB; Simonpietri JJ; Batista FC
    J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal regeneration following use of ABM/P-1 5: a case report.
    Yukna R; Salinas TJ; Carr RF
    Int J Periodontics Restorative Dent; 2002 Apr; 22(2):146-55. PubMed ID: 12019710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
    J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment isolated Class I gingival recession of defects: a pilot study.
    Nazareth CA; Cury PR
    J Periodontol; 2011 May; 82(5):700-7. PubMed ID: 21080787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of human infrabony periodontal defects by grafting human cultured periosteum sheets combined with platelet-rich plasma and porous hydroxyapatite granules: case series.
    Okuda K; Yamamiya K; Kawase T; Mizuno H; Ueda M; Yoshie H
    J Int Acad Periodontol; 2009 Jul; 11(3):206-13. PubMed ID: 19753798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans.
    Lovelace TB; Mellonig JT; Meffert RM; Jones AA; Nummikoski PV; Cochran DL
    J Periodontol; 1998 Sep; 69(9):1027-35. PubMed ID: 9776031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical results on the use of bone-replacement grafts in the treatment of intrabony periodontal defects. Comparison of the use of autogenous bone graft plus calcium sulfate to autogenous bone graft covered with a bioabsorbable membrane.
    Orsini M; Orsini G; Benlloch D; Aranda JJ; Sanz M
    J Periodontol; 2008 Sep; 79(9):1630-7. PubMed ID: 18771362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of bovine derived xenograft with and without a bioabsorbable collagen membrane in the treatment of mandibular Class II furcation defects.
    Taheri M; Molla R; Radvar M; Sohrabi K; Najafi MH
    Aust Dent J; 2009 Sep; 54(3):220-7. PubMed ID: 19709109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    Int J Periodontics Restorative Dent; 2005 Feb; 25(1):49-59. PubMed ID: 15736778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of periodontal regeneration following grafting intrabony defects with bio-oss collagen: a human histologic report.
    Nevins ML; Camelo M; Lynch SE; Schenk RK; Nevins M
    Int J Periodontics Restorative Dent; 2003 Feb; 23(1):9-17. PubMed ID: 12617364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results.
    Yukna RA; Callan DP; Krauser JT; Evans GH; Aichelmann-Reidy ME; Moore K; Cruz R; Scott JB
    J Periodontol; 1998 Jun; 69(6):655-63. PubMed ID: 9660334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings.
    Yukna RA; Krauser JT; Callan DP; Evans GH; Cruz R; Martin M
    J Periodontol; 2002 Jan; 73(1):123-8. PubMed ID: 11846193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental intrabony and periodontal defects treated with natural mineral combined with a synthetic cell-binding Peptide in the canine: morphometric evaluations.
    Artzi Z; Weinreb M; Tal H; Nemcovsky CE; Rohrer MD; Prasad HS; Kozlovsky A
    J Periodontol; 2006 Oct; 77(10):1658-64. PubMed ID: 17032107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostim) or a bovine-derived xenograft (Bio-Oss) in combination with a collagen membrane (Bio-Gide). A case series.
    Schwarz F; Bieling K; Latz T; Nuesry E; Becker J
    J Clin Periodontol; 2006 Jul; 33(7):491-9. PubMed ID: 16820037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of human class II furcation defects using connective tissue grafts, bioabsorbable membrane, and resorbable hydroxylapatite: a comparative study.
    Belal MH; Al-Noamany FA; El-Tonsy MM; El-Guindy HM; Ishikawa I
    J Int Acad Periodontol; 2005 Oct; 7(4):114-28. PubMed ID: 16245642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.